SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 676.70 |
| Enterprise Value ($M) | 485.27 |
| Book Value ($M) | 265.52 |
| Book Value / Share | 5.34 |
| Price / Book | 2.55 |
| NCAV ($M) | 231.77 |
| NCAV / Share | 4.66 |
| Price / NCAV | 2.92 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 10.62 |
| Current Ratio | 10.62 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 310.68 |
| Assets | 344.43 |
| Liabilities | 78.91 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -133.34 |
| Net Income | -123.57 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -86.78 |
| Cash from Investing | -94.64 |
| Cash from Financing | 118.70 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Lightspeed Venture Partners Select IV, L.P. | 4.80 | 20.90 | |
| 13G/A | Deep Track Capital, LP | 5.99 | 0.00 | |
| 13G/A | Ra Capital Management, L.p. | 0.00 | -100.00 | |
| 13G/A | Flynn James E | 8.27 | 48.63 | |
| 13G/A | Carlyle Group Inc. | 3.80 | 0.00 | |
| 13D/A | Frazier Life Sciences Public Fund, L.P. | 20.20 | 0.26 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| Form 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,001 | 62,071 | 6.45 | |
| 15,392 | 53,803 | 28.61 | |
| 18,095 | 34,814 | 51.98 | |
| 16,158 | 38,673 | 41.78 | |
| 8,969 | 27,862 | 32.19 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| GRTS – Gritstone bio, Inc. | GTHX – G1 Therapeutics, Inc. |
| HALO – Halozyme Therapeutics, Inc. | HOWL – Werewolf Therapeutics, Inc. |
| HUMA – Humacyte, Inc. |
Financial data and stock pages provided by
Fintel.io